Attralus Bulletin

News, Press Releases, & Other Media
A purple and cyan fibril graphicA purple and cyan fibril graphic
all posts

All Posts

Press Releases

Press Releases

In the News

In the News
Note: Attralus, Inc. was formally known as Aurora Bio, Inc.
In the News
September 14, 2020
Attralus Eyes Further Work on Therapeutic Candidates with New Funding
www.biospace.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
In the News
September 14, 2020
Attralus Raises $25 Million to Transform Treatment for Patients with Systemic Amyloidosis
globalgenes.org
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
In the News
September 14, 2020
The Crunchbase News Briefing: Mon., Sept. 14
news.crunchbase.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
In the News
September 14, 2020
Attralus Raises $25M in Series A Financing
finsmes.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
In the News
September 14, 2020
Attralus Secures $25M Series A to Diagnose and Treat Amyloidosis
timmermanreport.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
In the News
September 14, 2020
Attralus debuts with $25M series A to tackle systemic amyloidosis
biocentury.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More

Get in Touch

Partnership, Careers, Press, OR PATIENT Inquiries

Thank you

Your message has been received!

We will reply as soon as possible.
Oops! Something went wrong while submitting the form.
A purple and cyan fibril graphic

our apologies

TABLET & MOBILE EXPERIENCES
ARE STILL UNDER CONSTRUCTION

Please view on a desktop or laptop computer.